Insider Profile
Di Sisto, Domenic
1
Companies Filed At
9
Open-Market Buys (2yr)
$41K
Buy Value (2yr, open-market)
Sep 30, 2025
Most Recent Trade
20
Credibility
Score
44%
Hit Rate
-5.1%
Avg 90d Return
-5.0%
Median 90d Return
36
Evaluated Trades
+20.5%
Best Trade
-35.8%
Worst Trade
Hit rate and returns are based on 36 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Cross-Company Track Record
30%
Hit Rate · 90d
-23.7%
Median Alpha · 90d
10
Closed Buys Evaluated
30%
Beat XIU
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
cluster buyer high frequency size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 10 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
Sep 30, 2025 $DCBO
Docebo
— Exercise Sell 381 — — 43
Sep 30, 2025 $DCBO
Docebo
— Open Market Buy 210 $37.91 $8K 43
Sep 30, 2025 $DCBO
Docebo
— Exercise Buy 381 — — 43
Sep 22, 2025 $DCBO
Docebo
— Open Market Buy 22 $41.69 $917 43
Sep 22, 2025 $DCBO
Docebo
— Exercise Buy 39 — — 43
Sep 22, 2025 $DCBO
Docebo
— Exercise Sell 39 — — 43
Aug 22, 2025 $DCBO
Docebo
— Exercise Buy 175 — — 43
Aug 22, 2025 $DCBO
Docebo
— Exercise Sell 175 — — 43
Aug 22, 2025 $DCBO
Docebo
— Open Market Buy 97 $42.66 $4K 43
Jun 20, 2025 $DCBO
Docebo
— Open Market Buy 22 $36.02 $792 43
Jun 20, 2025 $DCBO
Docebo
— Exercise Sell 39 — — 43
Jun 20, 2025 $DCBO
Docebo
— Exercise Buy 39 — — 43
May 22, 2025 $DCBO
Docebo
— Exercise Sell 703 — — 43
May 22, 2025 $DCBO
Docebo
— Exercise Buy 703 — — 43
May 22, 2025 $DCBO
Docebo
— Open Market Buy 387 $36.06 $14K 43
Mar 31, 2025 $DCBO
Docebo
— Exercise Buy 191 — — 43
Mar 31, 2025 $DCBO
Docebo
— Comp. Grant Buy 7,505 — — 43
Mar 31, 2025 $DCBO
Docebo
— Comp. Grant Buy 3,387 — — 43
Mar 31, 2025 $DCBO
Docebo
— Exercise Sell 191 — — 43
Mar 31, 2025 $DCBO
Docebo
— Open Market Buy 105 $41.60 $4K 43
Mar 20, 2025 $DCBO
Docebo
— Exercise Sell 39 — — 43
Mar 20, 2025 $DCBO
Docebo
— Exercise Buy 39 — — 43
Mar 20, 2025 $DCBO
Docebo
— Open Market Buy 22 $42.79 $941 43
Dec 31, 2024 $DCBO
Docebo
— Exercise Buy 191 — — 43
Dec 31, 2024 $DCBO
Docebo
— Open Market Buy 105 $64.41 $7K 43
Dec 31, 2024 $DCBO
Docebo
— Exercise Sell 191 — — 43
Dec 20, 2024 $DCBO
Docebo
— Exercise Buy 38 — — 43
Dec 20, 2024 $DCBO
Docebo
— Exercise Sell 38 — — 43
Dec 20, 2024 $DCBO
Docebo
— Open Market Buy 21 $67.00 $1K 43
Sep 20, 2024 $DCBO
Docebo
— Exercise Buy 17 $61.37 $1K 43
Sep 20, 2024 $DCBO
Docebo
— Exercise Sell 17 — — 43
Sep 20, 2024 $DCBO
Docebo
— Buyback Buy 22 — — 43
Jul 02, 2024 $DCBO
Docebo
— Exercise Sell 85 $52.45 $4K 43
Jul 02, 2024 $DCBO
Docebo
— Buyback Buy 105 — — 43
Jul 02, 2024 $DCBO
Docebo
— Exercise Buy 85 $52.45 $4K 43
Jun 20, 2024 $DCBO
Docebo
— Exercise Buy 17 $50.66 $861 43
Jun 20, 2024 $DCBO
Docebo
— Exercise Sell 17 $50.66 $861 43
Jun 20, 2024 $DCBO
Docebo
— Buyback Buy 22 — — 43
May 22, 2024 $DCBO
Docebo
— Comp. Grant Buy 2,810 $50.39 $142K 43
May 22, 2024 $DCBO
Docebo
— Comp. Grant Buy 5,629 $50.39 $284K 43
Apr 01, 2024 $DCBO
Docebo
— Exercise Buy 86 $66.38 $6K 43
Apr 01, 2024 $DCBO
Docebo
— Buyback Buy 105 — — 43
Apr 01, 2024 $DCBO
Docebo
— Exercise Sell 86 $66.38 $6K 43
Jan 02, 2024 $DCBO
Docebo
— Open Market Buy 105 $60.53 $6K 43
Jan 02, 2024 $DCBO
Docebo
— Exercise Buy 191 — — 43
Dec 31, 2023 $DCBO
Docebo
— Exercise Sell 191 — — 43
Sep 19, 2023 $DCBO
Docebo
— Exercise Buy 344 $55.24 $19K 43
Sep 19, 2023 $DCBO
Docebo
— Exercise Sell 344 $55.24 $19K 43
Sep 19, 2023 $DCBO
Docebo
— Buyback Buy 419 — — 43
Mar 20, 2023 $DCBO
Docebo
— Comp. Grant Buy 1,150 — — 43
Mar 20, 2023 $DCBO
Docebo
— Comp. Grant Buy 620 — — 43
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.